<DOC>
	<DOCNO>NCT02384096</DOCNO>
	<brief_summary>The study prospective , on-label , multi-center , blind , randomize control trial cross-over design evaluate effect Precision Spectra™ SCS System 's programming feature lead option .</brief_summary>
	<brief_title>A Study Evaluate Effect Precision Spectra™ Programming Features Lead Options Patient Outcomes</brief_title>
	<detailed_description>The study sub-study RELIEF - A Global Registry Evaluate Long-Term Effectiveness Neurostimulation Therapy Pain . The treatment consist permanent implant Precision Spectra™ SCS IPG either 32 contact CoverEdge™ Surgical Lead 2 percutaneous lead successful trial . Programming feature lead option Precision Spectra™ SCS System evaluate 3 month post-IPG activation . Following completion 3 month visit , subject continue follow 36 month per study requirement RELIEF Registry .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<criteria>Meets RELIEF Registry criterion inclusion Primary complaint persistent recurrent low back pain , without leg pain Signed valid , IRB/ECapproved inform consent form Meets RELIEF Registry criterion exclusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>stimulation</keyword>
	<keyword>implantable</keyword>
	<keyword>pulse generator</keyword>
	<keyword>back pain</keyword>
	<keyword>chronic pain</keyword>
	<keyword>leg pain</keyword>
</DOC>